SNT 2.94% 3.3¢ syntara limited

bronchitol is approved

  1. 1,235 Posts.
    lightbulb Created with Sketch. 6
    "On 18 October 2011, the Committee for Medicinal Products for Human Use (CHMP) recommended the
    granting of the marketing authorisation for the medicinal product Bronchitol for the treatment of cystic
    fibrosis as an add-on therapy to best standard of care. The company that applied for authorisation is
    Pharmaxis Pharmaceuticals Ltd."

    Excuse me if I go for personal best by saying, "thumbs up if this post is useful to you". :D

    Link found here for your own confirmation:

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/10/news_detail_001360.jsp&mid=WC0b01ac058004d5c1
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
-0.001(2.94%)
Mkt cap ! $39.40M
Open High Low Value Volume
3.4¢ 3.4¢ 3.3¢ $8.432K 255.5K

Buyers (Bids)

No. Vol. Price($)
3 16618 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 451765 2
View Market Depth
Last trade - 10.09am 01/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.